Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Fat Cats are back on?

<< Previous

Bullboard Posts

Next >>

Comment by biorunon Feb 02, 2022 8:07pm

105 Views

Post# 34391464

RE:RE:RE:RE:RE:RE:RE:RE:RE:Fat Cats are back on?

Tickle

How about we take an old crinkly skinned overweight hairless cat with skin dyschromia that just got infected with covid and give it tfc039, tfc 1067, anti-viral and slather it with anti-wrinkle cream and keloid scar treatment for good measure because it probably was in a few fights over the years.

if it survives, and turns into a new born tabby cat (with hair), we are all going to be millionaires. And Howard can be Time Magazine CEO of the year.

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?